Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
No fee travel credit cards come with key benefits that can enhance your travel experience. Learn what they are to make informed choices.
26,188 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Two fast-casual leaders headline the 2026 investor debate: a Mediterranean newcomer with fast expansion and a Mexican...
BYD again proves it can set records, this time overseas. The question for investors is how long that momentum lasts a...
NVIDIA stock has fallen over the past month, triggering worries about headlines and momentum. This article breaks dow...
Ethereum tests a critical barrier near $1,800 as traders watch for a breakout that could unlock a rally toward $2,000...
Astera Labs stock skyrocketed last month as multiple catalysts converged. This deep-dive breaks down the driving forc...
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
This article breaks down a thoughtful framework for predicting the path of prediction: this tesla stock after Tesla's...
XRP sits around $1.08 as traders sift through diverging metrics and rising sentiment. Analysts warn that the price pr...
ServiceNow stands near $112 ahead of July 22 earnings, with a bullish setup built on rising subscription growth, soli...
More than 60 analysts now rate the stock Buy as investors await the upcoming earnings release and assess cloud, adver...
A new mega-listing grabbed headlines by raising $26.5 billion, ranking just below SpaceX in U.S. market history. Read...